CMND.US Clearmind Medicine Inc. Common Shares

Healthcare Biotechnology USA Stocks
4.53 USD
Close of Nov 14, 2026
4.35 1,274
Market cap
USD 2.30M
P/E
-
P/B
0.18x
ROE
-70.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2026.

Is CMND.US undervalued?

Graham number

The Graham number of Clearmind Medicine Inc. Common Shares cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Clearmind Medicine Inc. Common Shares fundamental analysis

No fundamental analysis for Clearmind Medicine Inc. Common Shares yet.

Clearmind Medicine Inc. Common Shares stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Clearmind Medicine Inc. Common Shares

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and me…

Full company profile